167 related articles for article (PubMed ID: 21813463)
1. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.
Fielden MR; Adai A; Dunn RT; Olaharski A; Searfoss G; Sina J; Aubrecht J; Boitier E; Nioi P; Auerbach S; Jacobson-Kram D; Raghavan N; Yang Y; Kincaid A; Sherlock J; Chen SJ; Car B;
Toxicol Sci; 2011 Nov; 124(1):54-74. PubMed ID: 21813463
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat.
Fielden MR; Nie A; McMillian M; Elangbam CS; Trela BA; Yang Y; Dunn RT; Dragan Y; Fransson-Stehen R; Bogdanffy M; Adams SP; Foster WR; Chen SJ; Rossi P; Kasper P; Jacobson-Kram D; Tatsuoka KS; Wier PJ; Gollub J; Halbert DN; Roter A; Young JK; Sina JF; Marlowe J; Martus HJ; Aubrecht J; Olaharski AJ; Roome N; Nioi P; Pardo I; Snyder R; Perry R; Lord P; Mattes W; Car BD; ;
Toxicol Sci; 2008 May; 103(1):28-34. PubMed ID: 18281259
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
[TBL] [Abstract][Full Text] [Related]
4. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity.
Nie AY; McMillian M; Parker JB; Leone A; Bryant S; Yieh L; Bittner A; Nelson J; Carmen A; Wan J; Lord PG
Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489
[TBL] [Abstract][Full Text] [Related]
5. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
Uehara T; Minowa Y; Morikawa Y; Kondo C; Maruyama T; Kato I; Nakatsu N; Igarashi Y; Ono A; Hayashi H; Mitsumori K; Yamada H; Ohno Y; Urushidani T
Toxicol Appl Pharmacol; 2011 Sep; 255(3):297-306. PubMed ID: 21784091
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific mRNA signatures as fingerprints for carcinogenesis in mice induced by genotoxic and nongenotoxic hepatocarcinogens.
Kossler N; Matheis KA; Ostenfeldt N; Bach Toft D; Dhalluin S; Deschl U; Kalkuhl A
Toxicol Sci; 2015 Feb; 143(2):277-95. PubMed ID: 25410580
[TBL] [Abstract][Full Text] [Related]
7. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals.
Fielden MR; Brennan R; Gollub J
Toxicol Sci; 2007 Sep; 99(1):90-100. PubMed ID: 17557906
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
9. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Toxicol Sci; 2004 Jan; 77(1):19-34. PubMed ID: 14600272
[TBL] [Abstract][Full Text] [Related]
10. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
Ellinger-Ziegelbauer H; Gmuender H; Bandenburg A; Ahr HJ
Mutat Res; 2008 Jan; 637(1-2):23-39. PubMed ID: 17689568
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
Liu Z; Kelly R; Fang H; Ding D; Tong W
Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
[TBL] [Abstract][Full Text] [Related]
12. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity.
Elrick MM; Kramer JA; Alden CL; Blomme EA; Bunch RT; Cabonce MA; Curtiss SW; Kier LD; Kolaja KL; Rodi CP; Morris DL
Toxicol Pathol; 2005; 33(1):118-26. PubMed ID: 15805063
[TBL] [Abstract][Full Text] [Related]
13. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
14. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
[TBL] [Abstract][Full Text] [Related]
15. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
Nioi P; Pardo ID; Sherratt PJ; Snyder RD
Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
[TBL] [Abstract][Full Text] [Related]
16. Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.
Michel C; Desdouets C; Slaoui M; Isaacs KR; Roberts RA; Boitier E
Toxicol Sci; 2007 Sep; 99(1):58-69. PubMed ID: 17602206
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomics discrimination of potential hepatocarcinogenicity of non-genotoxic compounds in rat liver.
Yamada F; Sumida K; Uehara T; Morikawa Y; Yamada H; Urushidani T; Ohno Y
J Appl Toxicol; 2013 Nov; 33(11):1284-93. PubMed ID: 22806939
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
Suenaga K; Takasawa H; Watanabe T; Wako Y; Suzuki T; Hamada S; Furihata C
Mutat Res; 2013 Feb; 751(1):73-83. PubMed ID: 23183053
[TBL] [Abstract][Full Text] [Related]
19. Collaborative study on fifteen compounds in the rat-liver Comet assay integrated into 2- and 4-week repeat-dose studies.
Rothfuss A; O'Donovan M; De Boeck M; Brault D; Czich A; Custer L; Hamada S; Plappert-Helbig U; Hayashi M; Howe J; Kraynak AR; van der Leede BJ; Nakajima M; Priestley C; Thybaud V; Saigo K; Sawant S; Shi J; Storer R; Struwe M; Vock E; Galloway S
Mutat Res; 2010 Sep; 702(1):40-69. PubMed ID: 20656055
[TBL] [Abstract][Full Text] [Related]
20. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays.
Thomas RS; O'Connell TM; Pluta L; Wolfinger RD; Yang L; Page TJ
Toxicol Sci; 2007 Mar; 96(1):40-6. PubMed ID: 17114358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
